These data support previous literature from Nakatani et al, which demonstrated that the impact of GLP-1 agonist on gastric and small intestinal emptying via capsule endoscopy was significantly different in those with and without diabetic neuropathy (DN) (0:48:00 h in patients without DN vs 1:12:36 ± 1:04:30 h in patients with DN)21. The gene discussed is GCG; the disease is liver dysplastic nodule.